Navigation Links
New Inhalation Anthrax Vaccine

A new anthrax vaccine may offer a faster and easier way to protect the general population and soldiers at war in the event of // a deadly bioterror attack. Scientists have developed a powdered form of the vaccine that could potentially be inhaled through the nose, thus eliminating needle injections.

The new formulation is based on an anthrax recombinant protective antigen (rPA), a genetically engineered protein. Researchers say the powdered formula is more stable than the injected liquid version and can withstand wider temperature extremes, in more extreme conditions without refrigeration.

The vaccine has not yet been tested in humans, but investigators say clinical trials could be possible within the next two to three years.In laboratory tests using rabbits exposed to a lethal dose of inhalation anthrax, nasal immunization with the powder resulted in an 83-percent to 100-percent survival rate. The results are similar to the protection offered by the injected formula.
'"/>




Page: 1

Related medicine news :

1. Hypertension can be caused by Inhalation of Salt
2. Ranbaxy Launches Asthma Inhalation Capsule in India
3. Kerala Youth Die of Carbon Monoxide Inhalation
4. Anthrax drug doxycycline could stunt fetal growth
5. Drugs For Anthrax May Interfere With Oral Contraceptives
6. Cipro Has Cheaper Cousins to Treat Anthrax
7. Panacea Biotech To Market Anthrax Vaccine
8. Anthrax vaccine produced
9. Prototype Detector detects Anthrax Quickly
10. Effective And Economical Agent For Anthrax
11. Anthrax hammers immune system

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Inhalation Anthrax Vaccine

(Date:11/25/2009)..., DELMAR,Calif.,Nov.25()/PRNewswire-FirstCall/-...ldings Corporation(PinkSheets:ADHC),announcedtoday...tionsplatform,enablinginvestorstoeasilyaccesstimel...ewsystemcanbeaccessedat: http://www.americandivers...isimportantandournewwebsiteallowsustoprovidereleva...
(Date:11/25/2009)...ditional South American medicinal herb proves effe.... 25 (HealthDay News) -- An herb called Brazilian ...drugs, English researchers report. , Traditiona...s crenata to treat a range of health problems, in...is study is the first to scientifically prove the ...
(Date:11/25/2009)..., SANFRANCISCO,Nov.25/PRNewswire/--IntroducingP...colorcosmeticsandadvancedskincarededicatedtoprovid...iBeautyisthefirstprestigeskincareandcolorcosmeticb...tistryStores,withofficesinSanFranciscoandToronto,w...ailprofessionalswithover35yearsexperienceintheindu...
(Date:11/25/2009)... Dr. Neil J. Zemmel, a board...hing a new website utilizing the latest internet t...t and breast reconstruction procedures. The new si...eate an interactive web experience that’s de...ual tour of Dr. Zemmel’s practice. , ...
(Date:11/25/2009)... The American Society of Hem...rsquo;s publishing, education, and media company, ...” a dynamic science curriculum designed to s...e, in addition to exposing students to exciting ca... Washington (PRWEB) November 25, 2009 --...
Breaking Medicine News(10 mins):Health News:American Diversified Holdings Corporation Announces New Website 2Health News:Pari Beauty Professional Artistry 2Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 2Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 3Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 4Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3
...en just once per month, experts say , FRIDAY, Oct....g anemia in patients with severe kidney disease co...ing to a U.S. study. , Compared with conventional ...l Research Institute in New York, and colleagues. ...
...thopedic Institute of Chicago Offer Complimentary ...linical Study., CHICAGO, Oct. 19 , What: ... Stage IV breast cancer are eligib...ve for a protein called human epid...
...18 The following statement,is attributable to: Ro...Medical Association (AMA) welcomes today,s decisio...to issue a consumer warning,about the potentially ...med purchasers of health care. Achieving this goal...
...if., Oct. 18 The annual HMO,report card released ...ague,and incomplete that it does not allow consume...he report omits key consumer information including...CR)., FTCR noted that today,s release was timed t...
...18 The Association of,American Physicians and Sur...Serkes, director of policy and public affairs, in ...today to override President Bush,s veto,of a bill ...would,have spent almost as much money on doctors a...
...f., Oct. 18 Align,Technology, Inc. (Nasdaq: ALGN...od of straightening teeth without wires or bracket...ation Program by the Academy of General,Dentistry,... implementing continuing education. It was created...
Other Medicine News:Health News:Simpler Anemia Treatment May Help Kidney Patients 2Health News:Brain Screenings Offered to Breast Cancer Patients During Breast Cancer Awareness Month 2Health News:State's HMO 'Report Card' Fails in Meaningful Evaluation of Health Care Quality and Ignores Affordability 2Health News:State's HMO 'Report Card' Fails in Meaningful Evaluation of Health Care Quality and Ignores Affordability 3Health News:Doctors Applaud SCHIP Veto: Bill Supports Special Interests, Not Kids; Almost Half of Funds Go to Doctors & Seniors 2Health News:Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry 2Health News:Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry 3
(Date:11/25/2009)...dsandJOHANNESBURG,November25/PRNewswire/--,iThemba...nouncedtoday,thattheyhavesignedacollaborativeagree... Pyxis,sworldclasscomputationalchemistryandleaddis...ivisiontoprovidemedicinaland,syntheticchemistrysup...lclientnetwork.iThembaPharmaceuticalsandPyxisDisco...
(Date:11/25/2009)....,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announce...ROTECT-1(theProspectiveRandomizedOralTherapyEvalua...-B)inpatientswithmoderate-to-severeCrohn,sdiseased...tolerabilityprofile.Thestudydemonstratedevidenceof...efinedasa70-pointdecreaseintheCrohn,sDiseaseActivi...
(Date:11/24/2009)...PRNewswire/-- ,, WHAT:RomHoubens,aBelgianmantho...ent,wasactuallyfullyconsciousandawakeduringthattim...ynaVoxEyeMaxwasfeaturedinthesegmenttoillustratehow...lockcommunication. ,, WHEN:GoodMorningAmerica--...oxtech.com ,, WHO:RomHoubenswasanengineerin...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Emdeon Acquires eRx Network LLC 50665 1Emdeon Acquires eRx Network LLC 50665 2Emdeon Acquires eRx Network LLC 50665 3New Drug Could Work Against Leukemia 50663 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 2
...cals, a division of Wyeth (NYSE: WYE ), announced...(FDA) has issued an approvable letter for,the firs... the treatment of,adult patients with community-ac..., the FDA requested that Wyeth provide,additional ...ACIL for the,treatment of patients with CAP with i...
...val Benefit in Complete and Partial Respo...HEIGHTS, N.J., May 29 Genta,Incorporated (OTC Bul...erm,followup from a Phase 3 trial of the Company,s...dium) Injection, in patients with chronic,lymphocy...data show that,patients who achieved either a comp...
Other Medicine Technology:Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 2Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 3Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 4Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 5Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 6Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 2Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 3Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 4
O.R. Special Procedure Apron
Special Procedure Apron
Easy Wrap Apron
Disposable Monopolar NeedleElectrodes With Detachable Lead Wire
Medicine Products: